- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study Puts A Price Tag On Autism
Autism exacts a heavy toll on families across the country, but what is the financial cost of the disorder?
Autism exacts a heavy toll on families across the country, but what is the financial cost of the disorder?
Now we have an actual price tag: the lifetime cost of supporting a person with autism ranges from $1.4 million to $2.4 million in the United States, depending on whether the person also has an intellectual disability.
That’s according to a report published by JAMA Pediatrics, based on a literature review of studies on individuals with autism and their families.
Those numbers add up to a total cost of about $66 billion a year for children and $175 billion a year for adults. About 3.5 million people have autism in the U.S. For kids, the biggest costs were for early education services and loss of income for their parents. For adults, residential care or living accommodations and loss of individual income were the biggest factors.
Read the full story here: http://bit.ly/1n3UcPw
Source: Kaiser Health News
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
